Claritev Corp (CTEV) SEC Filings & Earnings Calls

Net loss remains significant at $59.2M, though improved from $62.6M in Q2 2025.

“Net loss of $59.2 million for Q2 2026, compared to net loss of $62.6 million for Q2 2025.” · word for word

Adjusted EBITDA margin declined to 60.5% from 63.8% in Q2 2025.

“Adjusted EBITDA Margin of 60.5% versus 63.8% in Q2 2025.” · word for word

High leverage and interest expense

“Interest expense $100,253 and $99,746 for the three months ended June 30, 2026 and 2025, respectively.”

Negative equity / going concern risk

“Total shareholders' deficit $287,839 as of June 30, 2026.”

Antitrust litigation

“We have been named in numerous federal lawsuits, including putative class action lawsuits relating to litigation on the basis of alleged violation of antitrust laws.” · word for word

Loss of board member; temporary gap in Audit Committee; minimal operational impact.

“Death of board member John Prince; served on Audit Committee.”

Remaining civil investigative demand from DOJ; ongoing cooperation required.

“Company received a civil investigative demand from the Antitrust Division and is cooperating fully.” · word for word

Negative free cash flow and declining cash balance indicate liquidity pressure.

“Free Cash Flow of $(92.5)M; cash and equivalents $21.3M.”

Net loss widened slightly year-over-year.

“Net loss of $73.6M vs $71.3M.”

High leverage and interest expense

“Interest expense $99,542 for the three months ended March 31, 2026, up from $91,636 in the prior year period.”

Negative operating cash flow

“Net cash used in operating activities ($45,779) for the three months ended March 31, 2026.”

Antitrust litigation exposure

“We have been named in numerous federal lawsuits, including putative class action lawsuits relating to litigation on the basis of alleged violation of antitrust laws.” · word for word

High leverage and interest expense

“Interest expense $392.0M in 2025 vs $326.4M in 2024”

Negative free cash flow

“Free cash flow ($12.3M) in 2025”

History of goodwill impairment

“Loss on impairment of goodwill and intangible assets $1,488.9M in 2024” · word for word

High leverage and debt service risk

“Our level of indebtedness and current leverage may materially and adversely affect our ability to raise additional capital to fund our operations or growth and limit our ability to react to changes in the economy or our industry.” · word for word

Interest rate risk on variable debt

“All of the borrowings by MPH under the senior secured credit facilities bear interest at variable rates.” · word for word

Antitrust litigation exposure

“The increase of $70.6 million ... was primarily due to ... $16.9 million of antitrust related legal costs.”

Transformation execution risk

“Transformation costs represent costs directly associated with our multi-year transformation program called Vision 2030.” · word for word

Net loss continues though significantly narrowed; FY2025 net loss $284.3M.

“Net loss of $284.3 million for FY 2025” · word for word

Free cash flow negative for FY2025 at -$12.3M, though expected to turn positive in FY2026.

“Free cash flow of $(12.3) million for FY 2025” · word for word

High capex guidance of $160-$170M for FY2026 relative to revenue and FCF.

“Capital expenditures of $160 million to $170 million” · word for word

Litigation risk from healthcare providers

“Healthcare providers have become more resistant to the use of cost management techniques and are engaging in litigation to avoid application of cost management practices.” · word for word

ERP implementation risk

“We are in the process of implementing a new enterprise resource planning ("ERP") system, SAP... Any material weakness in the design and implementation of the new ERP system could also result in potentially materially higher costs.” · word for word

Negative free cash flow in Q3 2025 ($16.3M) vs positive $41.1M in prior year, indicating working capital pressure.

“Free Cash Flow of $(16.3) million for Q3 2025, compared to Free Cash Flow of $41.1 million for Q3 2024.” · word for word

Operating cash flow declined significantly to $19.9M from $72.8M YoY.

“Net cash provided by operating activities of $19.9 million for Q3 2025, compared to net cash provided by operating activities of $72.8 million for Q3 2024.” · word for word